Eloralintide for osteoarthritis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Jan 2026: Trial registered, NCT07353931
  2. 9 Feb 2026: Trial started, NCT07353931

The trials

NCT07353931: Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

State
Under way
Phase
Phase 3
People
900 planned
Started
9 Feb 2026
Primary completion
Mar 2028
Arms
Eloralintide (YOA1), Eloralintide (YOA2)
Results
None posted
  1. 21 Jan 2026: Trial registered
  2. 9 Feb 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.